Simplex Trading’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
VCM
Simplex Trading's INMB Position: Q1 2026 in Review
Simplex Trading reduced its INmune Bio (INMB) stake by 58% in Q1 2026, selling an estimated $6.59K and leaving 3,366 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #8057.
Simplex Trading first reported a position in INMB in Q2 2021 and has held it in 17 quarters since. The position peaked at $334K in Q1 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.
- Simplex Trading held 3,366 shares of INmune Bio worth $3.8K as of Q1 2026.
- Simplex Trading sold 4,623 INmune Bio shares in Q1 2026, an estimated $6.59K.
- INmune Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8057 holding.
- Simplex Trading first reported a position in INmune Bio in Q2 2021 and has held it in 17 quarters since.
- Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
- 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.